| Date Filed | Type | Description |
| 03/09/2023 |
4
| DEPTULA-HICKS DARLENE M (See Remarks) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 30,898 shares
@ $7.12, valued at
$220k
Disposed/sold 25,539 shares
@ $7.12, valued at
$181.8k
Disposed/sold 28,426 options to buy
@ $16.62, valued at
$472.4k
Disposed/sold 25,894 options to buy
@ $7.34, valued at
$190.1k
Disposed/sold 59,823 options to buy
@ $4.77, valued at
$285.4k
Disposed/sold 24,902 options to buy
@ $3.55, valued at
$88.4k
|
|
| 04/04/2022 |
4
| DEPTULA-HICKS DARLENE M (Treasurer and CFO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 24,902 options to buy
@ $3.55, valued at
$88.4k
|
|
| 01/11/2022 |
4
| DEPTULA-HICKS DARLENE M (Treasurer and CFO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 59,823 options to buy
@ $4.77, valued at
$285.4k
|
|
| 08/24/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| DEPTULA-HICKS DARLENE M (Treasurer and CFO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 28,426 options to buy
@ $16.62, valued at
$472.4k
Granted 26,437 restricted stock units
@ $0 |
|
| 11/24/2020 |
3
| DEPTULA-HICKS DARLENE M (Treasurer and CFO) has filed a Form 3 on F-star Therapeutics, Inc. |
| 08/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4/A
| DEPTULA-HICKS DARLENE M (Director) has filed a Form 4 on Xenetic Biosciences, Inc.|
Txns:
| Granted 10,000 options
@ $3.5, valued at
$35k
|
|
| 06/15/2017 |
3/A
| DEPTULA-HICKS DARLENE M (Director) has filed a Form 3/A on Xenetic Biosciences, Inc. |
| 06/08/2017 |
4
| DEPTULA-HICKS DARLENE M (SVP & CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Bought 4,000 shares
@ $3.58, valued at
$14.3k
|
|
| 05/02/2017 |
4
| DEPTULA-HICKS DARLENE M (CFO) has filed a Form 4 on T2 Biosystems, Inc. |
| 05/02/2017 |
3
| DEPTULA-HICKS DARLENE M (CFO) has filed a Form 3 on T2 Biosystems, Inc. |
| 12/23/2016 |
4
| DEPTULA-HICKS DARLENE M (Director) has filed a Form 4 on Xenetic Biosciences, Inc. |
| 11/15/2016 |
3
| DEPTULA-HICKS DARLENE M (Director) has filed a Form 3 on Xenetic Biosciences, Inc. |
| 06/15/2016 |
4
| DEPTULA-HICKS DARLENE M (SVP, CFO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
| 09/03/2015 |
4
| DEPTULA-HICKS DARLENE M (Sr. Vice President and CFO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 450,000 options to buy
@ $2.8, valued at
$1.3M
|
|
| 03/31/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2011 |
4
| DEPTULA-HICKS DARLENE M (Exec VP Finance, CFO) has filed a Form 4 on ICAD INC|
Txns:
| Paid exercise price by delivering 5,108 shares
@ $1.24, valued at
$6.3k
|
|
| 07/21/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/11/2010 |
4
| DEPTULA-HICKS DARLENE M (Executive VP of Finance, CFO) has filed a Form 4 on ICAD INC|
Txns:
| Sold 201 shares
@ $1.41, valued at
$283.4
Sold 100 shares
@ $1.41, valued at
$141
Sold 5,070 shares
@ $1.4, valued at
$7.1k
Sold 19,629 shares
@ $1.4, valued at
$27.5k
|
|
| 03/03/2010 |
4
| DEPTULA-HICKS DARLENE M (Exec VP of Finance, CFO) has filed a Form 4 on ICAD INC|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 07/21/2009 |
4
| DEPTULA-HICKS DARLENE M (Executive VP of Finance, CFO) has filed a Form 4 on ICAD INC |